Recombinant Human Serpin G1 His-tag Protein, CF

R&D Systems | Catalog # 10951-PI

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems CHO-derived Recombinant Human Serpin G1 His-tag Protein (10951-PI)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

P05155.2

Applications

Enzyme Activity
View all Serpin G1/C1 Inhibitor Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Serpin G1/C1 Inhibitor protein
Asn23-Ala500 with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Asn23

Predicted Molecular Mass

54 kDa

SDS-PAGE

89-98 kDa, under reducing conditions

Activity

Measured by its ability to inhibit Recombinant Human Complement Component C1s (Catalog # 2060-SE) cleavage of a colorimetric peptide substrate, N-carbobenzyloxy-Lys-ThioBenzyl ester (Z-K-SBzl).
The IC50 is <5 nM, as measured under the described conditions.

Scientific Data Images for Recombinant Human Serpin G1 His-tag Protein, CF

Recombinant Human Serpin G1 His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human Serpin G1 His-tag Protein (Catalog # 10951-PI) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 89-98 kDa.

Formulation, Preparation, and Storage

10951-PI
Formulation Lyophilized from a 0.2 μm filtered solution in Sodium Acetate and NaCl.
Reconstitution Reconstitute at 0.5 mg/mL in sterile, deionized water.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Serpin G1/C1 Inhibitor

C1-inhibitor (C1-INH), also known as Serpin G1, is a 478 amino acid acute phase plasma glycoprotein member of the serpin superfamily of serine protease inhibitors.  C1 inhibitor, like many other serpin family members, contains a highly conserved C-terminal serpin domain with a reactive center loop that protrudes to present a peptide for proteolytic attack (1). Binding disrupts the protease active site and traps it in a covalent complex with C1-inhibitor resulting in inactivation of the protease. C1 inhibitor also contains a highly glycosylated N- terminus and a unique C-terminal tail that has been suggested to serve as a barrier for transition to an inactive latent form (2). C1 inhibitor is synthesized and secreted primarily by hepatocytes but also by other cells such as monocytes, fibroblasts, and macrophages (1). C1 inhibitor is the sole physiological inhibitor of activated classical complement pathway serine proteases C1r and C1s (3). In addition, C1 inhibitor can inhibit multiple other serine proteases including plasma kallikrein and coagulation factor XIIa from the contact activation system, MASP-1 and MASP-2 proteases from the mannose binding lectin pathway, factor XIa and thrombin from the coagulation system, and plasmin and tissue plasminogen activator from the fibrinolytic system (3). Serpin G1 deficiency, whether caused by deletions, mutations, or inactivation, results in an autosomal dominantly inheritable potentially lethal disease, hereditary angioedema (HAE) (1). Some mutations in the SerpinG1 gene are also associated with age-related macular degeneration (4). Given the role C1-inhibitor plays as a potent anti-inflammatory agent, it has been developed for clinical use to treat HAE (1, 5) and considered for treatment of several other conditions including sepsis, acute myocardial infarction, brain injury, transplantation and COVID19 (6-11).

References

  1. Karnaukhova, E. (2013) J. Hematol. Thromb. Dis. 1:3.
  2. Beinrohr, L. et al. (2007) J. Biol. Chem. 282:21100.
  3. Davis, A.E. III (2010) Thromb. Haemost. 104:886.
  4. Ennis, S. et al. (2008) Lancet 372:1828.
  5. Cicardi, M and A. Zanichelli (2010) Drugs Today. 46:867.
  6. Caliezi, C. et al. (2000) Pharmacol. Rev. 52:91.
  7. Thielmann, M. et al. (2006) Eur. J. Cardiothorac. Surg. 30:285.
  8. Singer, M. and Jones, A.M. (2011) Crit. Care 15:203.
  9. Berger, M. et al. (2016) Transplantation 100:1415.
  10. Weiss, E. et al. (2020) Clin. Exp. Emerg. Med. 7:87.
  11. Adesanya, T.M.A. et al. (2021) J. Clin. Immunol. 41:729.

Alternate Names

C1 Inhibitor

Entrez Gene IDs

710 (Human)

Gene Symbol

SERPING1

UniProt

P05155.2

Additional Serpin G1/C1 Inhibitor Products

Product Documents for Recombinant Human Serpin G1 His-tag Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Serpin G1 His-tag Protein, CF

For research use only

Customer Reviews for Recombinant Human Serpin G1 His-tag Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Serpin G1 His-tag Protein, CF and earn rewards!

Have you used Recombinant Human Serpin G1 His-tag Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Serpin G1 His-tag Protein, CF (10951-PI):

Materials
  • Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, and 0.05% Brij-35 (w/v), pH 7.5 (TCNB)
  • Recombinant Human Serpin G1 (Catalog # 10951-PI)
  • Recombinant Human Complement Component C1s (rhC1s) (Catalog # 2060-SE)
  • Substrate: L-Lys-SBzl (Bachem, Catalog # M-1300), 10 mM stock in DMSO
  • 5,5'-Dithobis(2-Nitrozenzoic acid) (DTNB) (Sigma, Catalog # D8130), 10 mM stock in DMSO
  • 96-well Clear Plate (Catalog # DY990)
  • Fluorescent Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Dilute rhC1s to 2 µg/mL in Assay Buffer.
  2. Prepare a curve of rhSerpin G1 (MW: 54,000 Da) in Assay Buffer. Make the following serial dilutions: 2000, 1000, 500, 100, 50, 25, 12.5, 4, 0.8, and 0.2 nM.
  3. Combine 25 µL of diluted rhC1s and 25 µL of rhSerpin G1 at each concentration of the curve. Include a Control containing 25 µL of Assay Buffer and 25 µL of diluted rhC1s.
  4. Incubate mixtures at room temperature for 30 minutes.
  5. Dilute the mixtures 5-fold by adding 200 µL of Assay Buffer to each reaction and control vial.
  6. Dilute the Substrate to 200 µM with Assay Buffer containing 200 µM DTNB.
  7. Load into plate 50 µL of the diluted incubated mixtures and start the reaction by adding 50 µL of 200 µM Substrate/200 µM DTNB mixture. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of 200 µM Substrate/ µM DTNB mixture.
  8. Read at an absorbance wavelength of 405 nm in kinetic mode for 5 minutes.
  9. Derive the 50% inhibition concentration (IC50) value for rhSerpin G1 by plotting OD/min (or specific activity) versus concentration with 4-PL fitting.
  10. The specific activity for rhC1s at each point may be determined using the following formula (if needed):

     Specific Activity(pmol/min/µg) =

Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/mol
(ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (μg)

   

*Adjusted for Substrate Blank
**Using the extinction coefficient 13260 M-1cm-1
***Using the path correction 0.32 cm
Note: the output of the many spectrophotometers is in mOD

Per Well:

  • rhSerpin G1 curve: 100, 50, 25, 5, 2.5, 1.25, 0.625, 0.2, 0.04, and 0.01 nM
  • rhC1s: 0.01 µg
  • Substrate: 100 µM
  • DTNB: 100 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes